Newsroom

香港--(BUSINESS WIRE)--（ビジネスワイヤ） -- オアシス・マネジメント・カンパニー・リミテッド(TOKYO: 9468)： Q1. オアシスとはどのような会社で、いつ頃からKADOKAWAとの対話を行っているのか？ オアシス・マネジメント・カンパニー・リミテッド（以下「オアシス」または「当社」）は、長期的な投資家であり、高い調査力を重視した投資運用会社です。オアシスが運用するファンドは、2020年から継続して、株式会社KADOKAWA（以下「KADOKAWA」または「同社」）の株主であり、現在は同社株式の約13.76%を保有しています。 過去6年間にわたり、オアシスは、経営陣との面談、IR面談、正式な書簡などを通じて、KADOKAWAの経営陣および取締役会と幅広く対話を重ねてきました。過去の対話を通じてオアシスは一貫して、KADOKAWAが有する世界的なIP（知的財産）ポートフォリオのさらなる活用、コスト規律の強化、資本配分の改善、そしてより強固なガバナンスの実現を求めてきました。 Q2. なぜ、オアシスはKADOKAWAに投資をしているのか？ オアシスがKADO...

HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (TOKYO: 9468): Q1. Who is Oasis, and how long has Oasis been engaged with KADOKAWA? Oasis Management Company Ltd. (“Oasis”) is a long-term, research-driven investment manager whose funds have been shareholders of KADOKAWA CORPORATION (“KADOKAWA” or the “Company”) since 2020 and currently own approximately 13.76% of the Company’s shares. Over the past six years, Oasis has engaged extensively with KADOKAWA’s management and Board through me...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF. “Hello from issue 58 of our weekly report. This week, I would like to share two key updates with everyone: first, our upcoming major launch events; and second, an important breakthrough in our robotics education ecosystem. Sin...

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recover...

Halifax--(BUSINESS WIRE)--A tentative agreement has been reached between the Canadian Union of Public Employees (CUPE) Local 1082 and St. Vincents Nursing Home. CUPE 1082 is the Lead Table in bargaining, responsible for negotiating terms that impact other bargaining tables, including setting the economic pattern for CUPE members in the long term care sector in Nova Scotia. Details of the tentative agreement will not be shared until members have had the opportunity to review and ratify the terms...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the presentation of new data from its CATALYST and MOMENTUM trials at the American Diabetes Association’s 86th Scientific Sessions. The presentations underscore the critical role of...

SAN DIEGO--(BUSINESS WIRE)--A class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”), drones, robotics, electric vehicles...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of Dexcom G7 leads to clinically and statistically significant reduction in A1C and improvement in glucose control among people with Type 2 diabetes not using insulin compared with a routine care control group using self-monitoring of blood glucose.1 Researchers presented these results today as an oral presentation at the 2026 Scientific Sessions of...

TORONTO--(BUSINESS WIRE)--Kalloghlian Myers LLP is investigating a potential investor class action against TerraVest Industries Inc. (TSE: TVK). On June 5, 2026, TerraVest shares fell 31.6% following allegations that executive chairman Charles Pellerin tipped off family members and acquaintances ahead of a major acquisition announcement. The Journal de Montréal reported that Québec’s financial regulator obtained a search warrant, citing allegations that Pellerin communicated privileged informat...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented detailed results from multiple Phase 2b studies of berobenatide (PF’3944), an investigational, potential first-in-class monthly GLP-1 receptor agonist (GLP-1 RA) peptide, during a late-breaking expert symposium at the 86th Scientific Sessions of the American Diabetes Association (ADA). The objectives for the Phase 2 studies were to identify the right doses for Phase 3 and to test escalation schemes. Across both weekly and monthl...